washington following years research testing u.s. food drug administration officially approved groundbreaking artificial tumor tuesday marking time synthetic malignant growth cleared use patients country obviously significant complications devising tumor substitute human body accept artificial neoplasm serves physiological functions organic abnormal growth tissue said jeffrey shuren fda center devices radiological health adding polymer based lump safely implanted patients regardless age health medical history minimally invasive relatively quick hour surgical procedure synthetic tumor remarkably lightweight malignant capable naturally metastasizing body benefit incredibly small roughly size dime body grow times size work immediately replicating shuren added initial prototypes device battery power days approved